Current Report Filing (8-k)
03 Febbraio 2023 - 10:16PM
Edgar (US Regulatory)
0000051143
false
Capital stock, par value $.20 per share
IBM
CHX
0000051143
2023-01-30
2023-01-30
0000051143
us-gaap:CommonStockMember
exch:XCHI
2023-01-30
2023-01-30
0000051143
us-gaap:CommonStockMember
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes1.25PercentDue2023Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes1.125PercentDue2024Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes2.875PercentDue2025Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes0.950PercentDue2025Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes0.875PercentDue2025Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes0.300PercentDue2026Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes1.250PercentDue2027Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes0.300PercentDue2028Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes1.750PercentDue2028Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes1.500PercentDue2029Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes0.875PercentDue2030Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Notes1.750PercentDue2031Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
exch:XNYS
ibm:Notes0.650PercentDue2032Member
2023-01-30
2023-01-30
0000051143
exch:XNYS
ibm:Notes1.250PercentDue2034Member
2023-01-30
2023-01-30
0000051143
exch:XNYS
ibm:Notes1.200PercentDie2040Member
2023-01-30
2023-01-30
0000051143
ibm:Debentures7.00PercentDue2025Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Debentures6.22PercentDue2027Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Debentures6.50PercentDue2028Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Debentures5.875PercentDue2032Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Debentures7.00PercentDue2045Member
exch:XNYS
2023-01-30
2023-01-30
0000051143
ibm:Debentures7.125PercentDue2096Member
exch:XNYS
2023-01-30
2023-01-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
| Title of each class |
Capital stock, par value $.20 per share |
| Trading
symbol |
IBM |
|
Common Stock |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: January 30, 2023
(Date of earliest
event reported)
INTERNATIONAL
BUSINESS MACHINES CORPORATION
(Exact name of registrant
as specified in its charter)
| New York |
|
1-2360 |
|
13-0871985 |
| (State of Incorporation) |
|
(Commission File Number) |
|
(IRS employer Identification No.) |
One New Orchard Road
|
|
|
| Armonk,
New York |
|
10504 |
| (Address of principal executive offices) |
|
(Zip Code) |
914-499-1900
(Registrant’s telephone number)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered
pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
symbol(s) |
|
Name
of each exchange
on which registered |
| Capital stock, par value $.20 per share |
|
IBM |
|
New York Stock Exchange |
| |
|
|
|
NYSE Chicago |
| 1.250% Notes due 2023 |
|
IBM 23A |
|
New York Stock Exchange |
| 1.125% Notes due 2024 |
|
IBM 24A |
|
New York Stock Exchange |
| 2.875% Notes due 2025 |
|
IBM 25A |
|
New York Stock Exchange |
| 0.950% Notes due 2025 |
|
IBM 25B |
|
New York Stock Exchange |
| 0.875% Notes due 2025 |
|
IBM 25C |
|
New York Stock Exchange |
| 0.300% Notes due 2026 |
|
IBM 26B |
|
New York Stock Exchange |
| 1.250% Notes due 2027 |
|
IBM 27B |
|
New York Stock Exchange |
| 0.300% Notes due 2028 |
|
IBM 28B |
|
New York Stock Exchange |
| 1.750% Notes due 2028 |
|
IBM 28A |
|
New York Stock Exchange |
| 1.500% Notes due 2029 |
|
IBM 29 |
|
New York Stock Exchange |
| 0.875% Notes due 2030 |
|
IBM 30 |
|
New York Stock Exchange |
| 1.750% Notes due 2031 |
|
IBM 31 |
|
New York Stock Exchange |
| 0.650% Notes due 2032 |
|
IBM 32A |
|
New York Stock Exchange |
| 1.250% Notes due 2034 |
|
IBM 34 |
|
New York Stock Exchange |
| 1.200% Notes due 2040 |
|
IBM 40 |
|
New York Stock Exchange |
| 7.00% Debentures due 2025 |
|
IBM 25 |
|
New York Stock Exchange |
| 6.22% Debentures due 2027 |
|
IBM 27 |
|
New York Stock Exchange |
| 6.50% Debentures due 2028 |
|
IBM 28 |
|
New York Stock Exchange |
| 5.875% Debentures due 2032 |
|
IBM 32D |
|
New York Stock Exchange |
| 7.00% Debentures due 2045 |
|
IBM 45 |
|
New York Stock Exchange |
| 7.125% Debentures due 2096 |
|
IBM 96 |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02(e). Compensatory Arrangements of Certain Officers.
The following are compensation arrangements for Arvind Krishna, the
Company’s Chairman and Chief Executive Officer and the Company’s named executive officers identified in the 2022 Proxy Statement.
Further information regarding the structure of the compensation programs and awards will be included in the Company’s 2023 Proxy
Statement.
| | |
2022 Annual | | |
2023 Cash | | |
2023 Long-Term Incentive Award* | |
| | |
Incentive
Payout | | |
Salary Rate | | |
Annual
Incentive Target | | |
Performance
Share Units | | |
Restricted
Stock Units | | |
Stock
Options | |
| A. Krishna | |
$ | 3,480,000 | | |
$ | 1,500,000 | | |
$ | 3,000,000 | | |
$ | 10,200,000 | | |
$ | 3,400,000 | | |
$ | 3,400,000 | |
| J.J. Kavanaugh | |
$ | 1,665,760 | | |
$ | 1,096,000 | | |
$ | 1,479,000 | | |
$ | 5,955,000 | | |
$ | 1,985,000 | | |
$ | 1,985,000 | |
| Gary Cohn | |
$ | 1,832,800 | | |
$ | 1,170,000 | | |
$ | 1,580,000 | | |
$ | 4,350,000 | | |
$ | 1,450,000 | | |
$ | 1,450,000 | |
| Tom Rosamilia** | |
$ | 1,218,060 | | |
$ | 894,000 | | |
$ | 1,206,000 | | |
$ | 0 | | |
$ | 0 | | |
$ | 0 | |
| M.H. Browdy | |
$ | 1,466,240 | | |
$ | 936,000 | | |
$ | 1,264,000 | | |
$ | 3,780,000 | | |
$ | 1,260,000 | | |
$ | 1,260,000 | |
*The Long-Term Incentive Awards will be granted on February 21,
2023. The actual number of Performance Share Units and Restricted Stock Units granted on this date will be based on the average of IBM’s
closing stock price for the 30 active trading days prior to the grant date. The Actual Number of Stock Options granted on this date will
be based on the same IBM closing stock price, but the stock price will also be multiplied by a valuation factor of .1667 to reflect the
discounted value of stock options on the grant date. The exercise price of the options will be equal to the average of IBM’s
high and low stock price on the date of grant. The Performance Share Units will be paid out in February 2026. The Restricted Stock
Units and Stock Options will vest 25% per year on each anniversary of the date of grant. Additional information about equity grants will
be provided in the Company’s Proxy Statement.
** As previously disclosed by the Company, Mr. Rosamilia, Senior
Vice President, will retire from the Company by June 30, 2023.
IBM’s web site (www.ibm.com) contains a significant amount of
information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit
its various web sites from time to time, as information is updated and new information is posted.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| Date: February 3, 2023 |
|
| |
|
| |
|
|
| |
By: |
/s/ Frank Sedlarcik |
| |
|
Frank Sedlarcik |
| |
|
Vice President, Assistant General Counsel and Secretary |
Grafico Azioni International Business M... (NYSE:IBM)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni International Business M... (NYSE:IBM)
Storico
Da Apr 2023 a Apr 2024
